Results 161 to 170 of about 43,032 (254)

Home dialysis

Iryou kikigaku (The Japanese journal of medical instrumentation), 2016
openaire   +2 more sources

Targeted Delivery of mRNA to the Heart via Extracellular Vesicles or Lipid Nanoparticles

Journal of Extracellular Vesicles, Volume 15, Issue 6, June 2026.
ABSTRACT Efficient and specific delivery of mRNA to target tissues is critical for maximising therapeutic benefits while minimising off‐target effects and systemic toxicity. Systemic administration of mRNA using lipid nanoparticles (LNPs) or extracellular vesicles (EVs) typically leads to predominant accumulation in the liver.
Muhammad Nawaz, Benyapa Tangruksa, Sepideh Heydarkhan‐Hagvall, Franziska Kohl, Hernán González‐King Garibotti, Yujia Jing, Zahra Payandeh, Azadeh Reyahi, Karin Jennbacken, John Wiseman, Leif Hultin, Lennart Lindfors, Jane Synnergren, Hadi Valadi   +13 more
wiley   +1 more source

Transferring From Peritoneal Dialysis to Home or In-Center Hemodialysis: A Cohort Study of an Integrated Home Dialysis Model. [PDF]

Kidney Med
Mahmoud J, Desbiens LC, Elftouh N, Laurin LP, Nadeau-Fredette AC.   +4 more
europepmc   +1 more source

Risk Factors for Foot‐Related Hospitalisations in Adults With and Without Diabetes: A Systematic Review

Journal of Foot and Ankle Research, Volume 19, Issue 2, June 2026.
ABSTRACT Introduction Foot‐related conditions are a leading cause of all hospitalisations and amputations worldwide. Half of these foot‐related hospitalisations are in people without diabetes. Yet, few studies seem to have explored risk factors for foot‐related hospitalisations in populations with or without diabetes. This study aimed to systematically
Sucharitha R. Weerasuriya, Chanika Alahakoon, Nimantha Karunathilaka, Yuqi Zhang, Susanna M. Cramb, Peter A. Lazzarini   +5 more
wiley   +1 more source

The way home: a scoping review of public health interventions to increase the utilization of home dialysis in chronic kidney disease patients. [PDF]

BMC Nephrol
Yongphiphatwong N, Teerawattananon Y, Supapol P, Pandejpong D, Chuanchaiyakul T, Sutawong J, Gandhi N, Kiatkrissada N, Dabak SV, Anothaisintawee T.   +9 more
europepmc   +1 more source

Understanding the decision of parents to opt‐out of medically actionable secondary findings offered through genome sequencing

Journal of Genetic Counseling, Volume 35, Issue 3, June 2026.
Abstract Genomic sequencing (GS) for patients and families with rare disease creates the opportunity for precise diagnosis as well as the option to learn about medically actionable secondary findings (SF). Debate persists internationally on how to manage the analysis and disclosure of SF, especially in settings where service delivery models for GS are ...
Abigail Hansen, Stephanie Luca, Olivia Moran, Riyana Babul‐Hirji, Teresa B. Coe, Kalin Wilk, Daniel Assamad, Katharine Fooks, Viji Venkataramanan, Salma Shickh, Joyce Yan, Vercancy Wu, Lauren Badalato, Tugce B. Balci, Virginie Beausejour Ladouceur, Lauren Chad, Caitlin Chisholm, Meredith K. Gillespie, Lijia Huang, Olga Jarinova, Lynette Lau, Whiwon Lee, Michael P. Mackley, Christian R. Marshall, Roberto Mendoza‐Londono, Chantal F. Morel, Julie Richer, Sarah Sawyer, Dimitrios James Stavropoulos, Anna Szuto, Mark Tarnopolsky, Anita Villani, Laura Zahavich, Martin J. Somerville, Kym M. Boycott, Wendy J. Ungar, Robin Z. Hayeems   +36 more
wiley   +1 more source

Home Dialysis in Patients with Cardiovascular Diseases. [PDF]

Clin J Am Soc Nephrol
Reaves AC, Weiner DE, Weiner DE, Sarnak MJ.   +3 more
europepmc   +1 more source

European Recommendations for Transitioning the Care of Patients With Multiple Myeloma Treated With B‐Cell Maturation Antigen Bispecific Antibodies From Academic Hospitals to Community‐Based Centers and for Outpatient Step‐Up Dosing

eJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Introduction Safe outpatient delivery of B‐cell maturation antigen–targeting bispecific antibodies (BCMA‐BsAbs) in multiple myeloma (MM) is challenging, particularly during step‐up dosing (SUD). Standardized guidance for European community practice is limited.
María‐Victoria Mateos, Elena Zamagni, Massimo Gentile, Rachel Hall, Florence Lachenal, Mónica López Riñon, Rakesh Popat, Christof Scheid, Thomas Wolff, Isabel Perez‐Cruz, Mohamad Mohty   +10 more
wiley   +1 more source

An Engineered Nano‐Bridging Strategy Remodels the Immune Microenvironment of Esophageal Squamous Cell Carcinoma via STING Pathway Activation

MedComm, Volume 7, Issue 6, June 2026.
HA1@diABZI–HMGB1 serves as a synergistic immunomodulator for dismantling the immunosuppressive microenvironment of esophageal squamous cell carcinoma (ESCC), it integrates ESCC‐targeted recognition, HMGB1‐mediated macrophage–tumor cell bridging, and diABZI‐driven STING activation.
Chaofan Huang, Xin Tang, Yixiao Zhao, Dafu Xu, Congyong Sun, Chenlong Wang, Fei Xie, Fangyi Xu, Chao Luo, Li Zhang, Qilong Wang   +10 more
wiley   +1 more source

Corrigendum to "Pregnancies in Women With Kidney Failure on Home Dialysis in the United States" [<i>Kidney International Reports</i> Volume 9, Issue 4, April 2024, Pages 907-918]. [PDF]

Kidney Int Rep
Shah S, Weinhandl E, Leonard AC, Rachwal B, Verma P, Perl J, Christianson AL.   +6 more
europepmc   +1 more source